A Novel Strategy to Rebalance Immunity in ITP – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
In immune thrombocytopenia, tuning the enzymatic activity of CD38 restored regulatory T cell function through the deacetylase Sirt-1.
Working in patient cells and models, the authors show this approach rebalances immunity rather than broadly suppressing it, pointing to CD38 as a fresh therapeutic target that could explain durable responses in patients with ITP.”
Title: Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
Authors: Mingfang Zhu, Haoyi Wang, Yitong Xu, Yubin Li, Wanru Wang, Lingjun Wang, Ruixue Wang, Ping Zhang, Ruting Wang, Junying Cao, Lin Wang, Yan Shi, Ming Hou, Yu Hou
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters
-
Oct 28, 2026, 13:13Michael Cahillane: Three-Buffy-Coat Platelets – Strengthening Blood Supply Resilience
-
Oct 28, 2026, 13:05N. Mariana S. Vasquez: Antiplatelets vs Anticoagulants – Key Clinical Differences
-
Oct 28, 2026, 12:45Panithaya Chareonthaitawee: A Podcast Walk Through Anticoagulation
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score